Pfizer delayed the announcement of its COVID-19 vaccine until after the 2020 election when it thought Donald Trump was defeated.

Contracting a non-COVID lower respiratory tract infection raises the risk of death 2 to 7 times over the next month to a year ...

The report said Pfizer significantly lowered its tax bill by routing profits through Ireland and other jurisdictions.

Eastern time, the S&P 500 was down 0.8 per cent, the Dow Jones Industrial Average was down 0.3 per cent, and the Nasdaq ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

Pfizer's stock is cheap but faces operational challenges. Analyze its valuation and performance to make informed investment ...

Investing.com -- Moderna (NASDAQ: MRNA) shares dropped 13% pre-open on Monday as investors reacted to the weekend news that the U.S. Food and Drug Administration’s (FDA) top vaccine official, Dr.

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

A long-running struggle in Nigeria against fake medicines has become even harder because widespread economic hardship is driving up demand, experts say.